NCT04675944View on ClinicalTrials.gov

Effect of BIA 5-1058 on the Steady State Pharmacokinetics of Treprostinil

PHASE1CompletedINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

February 28, 2018

Primary Completion Date

May 25, 2018

Study Completion Date

May 25, 2018

Conditions
Pulmonary Arterial Hypertension
Interventions
DRUG

BIA 5-1058

200 mg (2 x 100 mg tablets), oral route

DRUG

treprostinil

1 mg (1 extended-release tablet), oral route

Trial Locations (1)

14050

PAREXEL International - Early Phase Clinical Unit, Berlin

All Listed Sponsors
lead

Bial - Portela C S.A.

INDUSTRY

NCT04675944 - Effect of BIA 5-1058 on the Steady State Pharmacokinetics of Treprostinil | Biotech Hunter | Biotech Hunter